Randomized Trial of Ibudilast for Methamphetamine Dependence
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2019
Price : $35 *
At a glance
- Drugs Ibudilast (Primary)
- Indications Substance-related disorders
- Focus Therapeutic Use
- Acronyms IBUD phII
- 29 Mar 2018 Results presented in the MediciNova media release.
- 29 Mar 2018 Primary endpoint Methamphetamine use has not been met, according to the MediciNova media release.
- 29 Mar 2018 Status changed from active, no longer recruiting to completed, according to the MediciNova media release.